GETI.B

201

-0.5%↓

AMBEA

124

+0.32%↑

ARJOB

27.14

-0.37%↓

MSON.B

10.95

-2.23%↓

ORX

26.75

+4.09%↑

GETI.B

201

-0.5%↓

AMBEA

124

+0.32%↑

ARJOB

27.14

-0.37%↓

MSON.B

10.95

-2.23%↓

ORX

26.75

+4.09%↑

GETI.B

201

-0.5%↓

AMBEA

124

+0.32%↑

ARJOB

27.14

-0.37%↓

MSON.B

10.95

-2.23%↓

ORX

26.75

+4.09%↑

GETI.B

201

-0.5%↓

AMBEA

124

+0.32%↑

ARJOB

27.14

-0.37%↓

MSON.B

10.95

-2.23%↓

ORX

26.75

+4.09%↑

GETI.B

201

-0.5%↓

AMBEA

124

+0.32%↑

ARJOB

27.14

-0.37%↓

MSON.B

10.95

-2.23%↓

ORX

26.75

+4.09%↑

Search

Vivesto AB

Abierto

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave

By Trading Economics

Ingresos

2.3M

-7.2M

BPA

-0.013

Empleados

4

EBITDA

-7.1M

Dividendos

By Dow Jones

Próximas Ganancias

27 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-25M

54M

Apertura anterior

0

Cierre anterior

0

Vivesto AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 feb 2026, 23:47 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

19 feb 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19 feb 2026, 23:39 UTC

Adquisiciones, fusiones, absorciones

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19 feb 2026, 23:38 UTC

Ganancias

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19 feb 2026, 23:38 UTC

Ganancias

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19 feb 2026, 23:38 UTC

Ganancias

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19 feb 2026, 23:37 UTC

Charlas de Mercado

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19 feb 2026, 23:34 UTC

Ganancias

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19 feb 2026, 23:34 UTC

Ganancias

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19 feb 2026, 23:33 UTC

Ganancias

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19 feb 2026, 23:33 UTC

Ganancias

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19 feb 2026, 22:13 UTC

Charlas de Mercado

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19 feb 2026, 22:08 UTC

Ganancias

Fairfax Financial 4Q Rev $8.11B >FFH.T

19 feb 2026, 22:07 UTC

Ganancias

Eldorado Gold 4Q EPS $1.19 >ELD.T

19 feb 2026, 22:06 UTC

Ganancias

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19 feb 2026, 22:05 UTC

Ganancias

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19 feb 2026, 22:05 UTC

Ganancias

Eldorado Gold 4Q Rev $577.2M >ELD.T

19 feb 2026, 22:04 UTC

Ganancias

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19 feb 2026, 22:04 UTC

Ganancias

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19 feb 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

19 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

19 feb 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

19 feb 2026, 21:43 UTC

Ganancias

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19 feb 2026, 21:42 UTC

Adquisiciones, fusiones, absorciones

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19 feb 2026, 21:42 UTC

Ganancias

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19 feb 2026, 21:41 UTC

Ganancias

Correct: St Barbara 1H Net Loss A$249,000

19 feb 2026, 21:40 UTC

Ganancias

St Barbara 1H Net Loss A$249 Million

19 feb 2026, 21:39 UTC

Ganancias

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19 feb 2026, 21:37 UTC

Ganancias

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19 feb 2026, 21:37 UTC

Ganancias

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Comparación entre iguales

Cambio de precio

Vivesto AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
help-icon Live chat